Cognitive deficits were similar to the effects of being hospitalized during illness or an age-related decline of 10 years in age.
Nearly two years after COVID-19 infection, folks with long COVID symptoms can experience a decline in cognitive function. Though, those who have reported a full recovery from the infection have not experienced this similar decline.
According to a study published in July in The LANCET, authors claimed that it’s unclear whether cognitive deficits following COVID infection improve over time, as previous studies have focused on hospitalized patients with up to a year follow-up.
To examine cognitive performance based on the effects of COVID-19, researchers monitored participants in the United Kingdom in two rounds: from July 12, 2021, to August 27, 2021 (Round 1), and from April 28, 2022, to June 21, 2022 (Round 2). Participants were gathered through the study’s “COVID Symptom Study,” smartphone app, which included those with and without COVID infection, with varying symptom durations.
Findings revealed that among the participants who completed Round 1 (3,335 participants) and round 2 (2,435), those who had previously tested positive for COVID had lower cognitive accuracy compared to negative controls. This impact was most common in individuals who had experienced symptoms for 12 weeks or more.
The cognitive deficits were similar to the effects of being hospitalized during illness or an age-related decline of 10 years in age. However, participants' self-reported recovery results revealed deficits were found only in positive COVID individuals who did not feel fully recovered, while those who reported complete recovery showed no cognitive deficits.
A longitudinal analysis spanning almost two years since initial infection indicated that cognitive deficits persisted over time for those affected by the virus. However, it was found that there was no evidence of COVID’s impact on average reaction time during tasks, given the role of processing speed in cognitive function.
The effects of long COVID are ‘long lasting,” affecting a massive portion of the population who were infected in 2020. The UK's Office for National Statistics estimated that as of January 2023, approximately 687,000 people in the UK were experiencing self-reported long COVID after an initial infection at least two years prior.
The cognitive deficits resulting to long COVID have the potential to influence both individual quality of life and more broad economic factors due to reduced work capacity and increased support needs, researchers suggested.
This study highlights the need for continued efforts to identify and support those affected by long COVID and cognitive impairment.
It’s suggested future research should focus on understanding recovery time and the functioning of individuals with ongoing symptoms following COVID-19.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More